Pura Vida Investments, LLC Milestone Pharmaceuticals Inc. Transaction History

Pura Vida Investments, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$3.53 - $9.5 $793,342 - $2.14 Million	-224,743 Reduced 37.67%	371,788 $1.47 Million
Q3 2022 Nov 14, 2022	SELL	$5.86 - $9.43 $2.29 Million - $3.69 Million	-390,880 Reduced 39.59%	596,531 $5.48 Million
Q1 2022 May 16, 2022	BUY	$4.1 - $8.24 $229,189 - $460,616	55,900 Added 6.0%	987,411 $6.34 Million
Q4 2021 Feb 14, 2022	BUY	$5.47 - $7.13 $444,158 - $578,948	81,199 Added 9.55%	931,511 $6.1 Million
Q3 2021 Nov 15, 2021	BUY	$5.28 - $6.29 $780,209 - $929,454	147,767 Added 21.03%	850,312 $4.86 Million
Q2 2021 Aug 16, 2021	BUY	$5.22 - $6.11 $1.23 Million - $1.44 Million	234,905 Added 50.23%	702,545 $3.86 Million
Q1 2021 May 12, 2021	BUY	$5.79 - $8.85 $102,135 - $156,114	17,640 Added 3.92%	467,640 $2.71 Million
Q4 2020 Feb 16, 2021	BUY	$5.57 - $7.66 $1.95 Million - $2.68 Million	350,000 Added 350.0%	450,000 $3.02 Million
Q3 2020 Nov 16, 2020	BUY	$3.34 - $9.8 $334,000 - $980,000	100,000 New	100,000 $732,000

28.7M

200

Ticker MIST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,010,900
Market Cap $66.6M
Description
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.